These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 3276987)
1. New drug therapy in peripheral vascular disease. Coffman JD Med Clin North Am; 1988 Jan; 72(1):259-65. PubMed ID: 3276987 [TBL] [Abstract][Full Text] [Related]
3. Hypertensive patients with Raynaud's phenomenon or intermittent claudication and their treatment with ketanserin. van Oene JC Drugs; 1988; 36 Suppl 1():148-51. PubMed ID: 3240729 [No Abstract] [Full Text] [Related]
4. Treatment of Raynaud's phenomenon with calcium channel blockers. Smith CR; Rodeheffer RJ Am J Med; 1985 Feb; 78(2B):39-42. PubMed ID: 3976694 [TBL] [Abstract][Full Text] [Related]
5. A prospective comparison of thromboembolic stockings, external sequential pneumatic compression stockings and heparin sodium/dihydroergotamine mesylate for the prevention of thromboembolic complications in urological surgery. Hansberry KL; Thompson IM; Bauman J; Deppe S; Rodriguez FR J Urol; 1991 Jun; 145(6):1205-8. PubMed ID: 2033693 [TBL] [Abstract][Full Text] [Related]
10. [Vasodilation caused by inhibition of calcium ions as a factor of increasing oxygen transport in peripheral vascular diseases]. Pola P; Savi L; Dal Lago A; Zucchiatti V Clin Ter; 1977 Jun; 81(5):417-31. PubMed ID: 884936 [No Abstract] [Full Text] [Related]
11. [Beta blockers and peripheral blood circulation. Can the restrictions for indication still be maintained?]. Diehm C MMW Munch Med Wochenschr; 1983 Jan; 125(2):27-8. PubMed ID: 6132334 [No Abstract] [Full Text] [Related]
12. Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis. Meyrick Thomas RH; Rademaker M; Grimes SM; MacKay A; Kovacs IB; Cook ED; Bowcock SM; Kirby JD Br J Dermatol; 1987 Aug; 117(2):237-41. PubMed ID: 3307894 [TBL] [Abstract][Full Text] [Related]
13. Quadrilateral peripheral vascular disease in the young adult. HERSHEY FB; PAREIRA MD; AHLVIN RC Circulation; 1962 Dec; 26():1261-9. PubMed ID: 13954122 [No Abstract] [Full Text] [Related]
14. Raynaud's phenomenon of the nipple: a treatable cause of painful breastfeeding. Anderson JE; Held N; Wright K Pediatrics; 2004 Apr; 113(4):e360-4. PubMed ID: 15060268 [TBL] [Abstract][Full Text] [Related]
15. Effects of nifedipine therapy on pulmonary Raynaud's in primary Sjögren's syndrome. Joseph BZ; Organek HW; Grant A; Axelrod DA Clin Exp Rheumatol; 1988; 6(4):409-10. PubMed ID: 3229032 [TBL] [Abstract][Full Text] [Related]
16. Raynaud's phenomenon: pathophysiologic features and treatment with calcium-channel blockers. Smith CR; Rodeheffer RJ Am J Cardiol; 1985 Jan; 55(3):154B-157B. PubMed ID: 3881908 [TBL] [Abstract][Full Text] [Related]
17. [INDIRECT FIBRINOLYTIC AND ANTICOAGULANT TREATMENT OF THROMBOSIS]. MENEGHINI P; AVANZI G Policlinico Prat; 1964 May; 71():803-20. PubMed ID: 14159143 [No Abstract] [Full Text] [Related]
18. CYCLANDELATE (CYCLOSPASMOL) IN THE TREATMENT OF PERIPHERAL CIRCULATORY DISEASES. SMITH AL Angiology; 1965 Jan; 16():1-7. PubMed ID: 14258038 [No Abstract] [Full Text] [Related]
19. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307 [TBL] [Abstract][Full Text] [Related]